Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination

Background: Hypotonic-hyporesponsive episode (HHE) after whole cell pertussis vaccination is a known adverse event. Less is known about the risk of HHE after administration of acellular pertussis vaccines. Methods: Using parental interviews, this study actively surveyed for HHE among infants after doses 1 and 2 of acellular pertussis vaccine. Results: We interviewed the parents of 52,531 infants. HHE was reported at a rate of 22.8 per 100,000 doses (95% CI: 11.8–39.9) of acellular pertussis vaccine, approximately 45 episodes per 100,000 children. Conclusions: These rates are lower than HHE rates reported after whole cell pertussis vaccines and within the range of HHE rates reported in other studies of acellular pertussis vaccines.

[1]  S. Halperin,et al.  Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentation. , 2007, Vaccine.

[2]  M. Gold,et al.  Hypotonic-Hyporesponsive Episode (HHE) as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. , 2004, Vaccine.

[3]  Benjamin Schwartz,et al.  General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). , 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[4]  H. Cody Meissner,et al.  Recommended childhood immunization schedule--United States, 2002. , 2002, MMWR. Morbidity and mortality weekly report.

[5]  M. Braun,et al.  Hypotonic–Hyporesponsive Episodes Reported to the Vaccine Adverse Event Reporting System (VAERS), 1996–1998 , 2000, Pediatrics.

[6]  M. Hanlon,et al.  Acellular vaccines for preventing whooping cough in children. , 1999, The Cochrane database of systematic reviews.

[7]  E. Miller.  Overview of recent clinical trials of acellular pertussis vaccines. , 1999, Biologicals : journal of the International Association of Biological Standardization.

[8]  S. Ellenberg,et al.  Report of a US Public Health Service Workshop on Hypotonic–Hyporesponsive Episode (HHE) After Pertussis Immunization , 1998, Pediatrics.

[9]  M. L. Ciofi Degli Atti,et al.  Hypotonic hyporesponsive episodes in eight pertussis vaccine studies. , 1997, Developments in biological standardization.

[10]  H. Hallander,et al.  Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. , 1997, Lancet.

[11]  M. Gahr,et al.  Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants. , 1996, The Journal of pediatrics.

[12]  H. Hallander,et al.  A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. , 1996, The New England journal of medicine.

[13]  J. Hopper.  Illness after Whooping Cough Vaccination. , 1961 .